A Randomized Open-label Crossover Study to Compare the Safety and Efficacy of ZP-Glucagon to Injectable Glucagon in the Treatment of Insulin-induced Hypoglycemia in Subjects With Type-1 Diabetes
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Zosano Pharma
- 08 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 Oct 2015 Positive results published in Zosano Pharma media release.
- 23 Jun 2015 According to Zosano Pharma media release, top-line data is anticipated around September 2015.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History